DVT Current Concept

DVT Current Concepts Dr Saeed Al-Shomimi King Fahad Hospital of University Khobar – Saudi Arabia 2005

Venous Thromboembolism Stasis Activation of Coagulation Vessel Damage Virchow's Triad

FREQUENTLY ENCOUNTERED ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

[object Object],[object Object]

[object Object],[object Object],[object Object],[object Object]

[object Object],[object Object],[object Object]

[object Object],[object Object],[object Object],[object Object],[object Object]

Autoimmune Vasculitis ,[object Object],[object Object],[object Object],[object Object],[object Object],Especially in young with no apparent cause

LAB ,[object Object],[object Object],[object Object],[object Object],[object Object]

RADIOLOGY ,[object Object],[object Object],[object Object],[object Object],[object Object]

GENERAL MEASURES ,[object Object],[object Object]

I-Anticoagulants ,[object Object],[object Object]

Contraindication ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

1-Heparin ,[object Object],[object Object],[object Object],[object Object],[object Object]

Advantages of LMWH over SH ,[object Object],[object Object]

Route of Admn. & Dose ,[object Object],[object Object]

2-WARFARIN ,[object Object],[object Object],[object Object]

Duration of anti-coagulant therapy ,[object Object],[object Object],[object Object]

BUT…What if treatment with anti-coagulant is contraindicated??? ,[object Object]

II-Thrombolytics ,[object Object],[object Object],[object Object]

III-Prophylaxis ,[object Object]

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],High risk of DVT Moderate risk of DVT

<0.1% <1% <10% Low-risk 0.1-1% 1-10% 10-40% Moderate-risk >1% 10-30% 40-80% High-risk Frequency of Fatal PE Frequency of Proximal Vein Thrombosis Frequency of Calf Vein Thrombosis Category

Anti-coagulants ,[object Object],[object Object]

BUT..WHAT IF THE ANTICOAGULANT IS C/I??? ,[object Object]

PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM International Consensus Statement (Guidelines according to scientific evidence) (Int. Angiol., June 2006)

[object Object],[object Object],[object Object],[object Object],[object Object],International Consensus Statement Reviewed/modified

GENERAL AND VASCULAR SURGICAL PATIENTS

THE RISK ,[object Object],[object Object],[object Object]

Prophylaxis ,[object Object],[object Object],[object Object],[object Object]

Recommendations ,[object Object],[object Object],[object Object],[object Object],[object Object]

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

THE RISK ,[object Object],[object Object]

Recommendations ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

THE RISK ,[object Object],[object Object],[object Object],[object Object],[object Object]

PROPHLAXIS ,[object Object],[object Object],[object Object],[object Object]

Recommendations ,[object Object],[object Object],[object Object]

Recommendations ,[object Object],[object Object]

DVT Current Concept

Recomendados

Recomendados

Mais conteúdo relacionado

Mais procurados

Mais procurados (20)

Destaque

Destaque (20)

Semelhante a DVT Current Concept

Semelhante a DVT Current Concept (20)

Mais de Saeed Al-Shomimi

Mais de Saeed Al-Shomimi (20)

Último

Último (20)

DVT Current Concept